Disappearance after chemotherapy of blocking serum factors as measured in vitro with lymphocytes cytotoxic to tumor cells.
D000293:Adolescent; D002294:Carcinoma, Squamous Cell / Q000276:immunology; D002460:Cell Line; D002813:Chondrosarcoma / Q000188:drug therapy / Q000276:immunology; D003561:Cytarabine / Q000627:therapeutic use*; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D005354:Fibrosarcoma / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D008080:Liposarcoma / Q000188:drug therapy / Q000276:immunology; D008175:Lung Neoplasms / Q000188:drug therapy / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology; D010001:Osteitis Deformans / Q000276:immunology; D012516:Osteosarcoma / Q000188:drug therapy / Q000276:immunology; D012208:Rhabdomyosarcoma / Q000188:drug therapy / Q000276:immunology
D003561:Cytarabine